Candel Therapeutics, Inc. (CADL) Q1 2025 Earnings
CADL·Reported May 13, 2025·Before market open
Diluted EPS came in at $0.13, beat the $-0.24 consensus by $0.37.
Diluted EPS
$0.13beat by $0.37
Consensus: $-0.24
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Candel Therapeutics, Inc.'s Q1 2025 earnings report.
Candel Therapeutics, Inc. (CADL) reported Q1 2025 earnings on May 13, 2025 before market open.
Candel Therapeutics, Inc. reported diluted EPS of $0.13 for Q1 2025.
EPS beat the consensus estimate of $-0.24 by $0.37.
You can read the 10-Q periodic report (0000950170-25-069833) directly on SEC EDGAR. The filing index links above go to sec.gov.